Investing.com – Tilray slumped Wednesday after more than tripling its cannabis sales in the second quarter, but at lower prices, prompting a wider-than-expected loss, leaving traders with little choice but to say "no" to weed stocks.
Tilray (NASDAQ:TLRY) reported a net loss of $0.36 a share, below consensus estimates from Investing.com for a net loss of $0.26 a share, sending the company’s shares about 14% lower. Tilray is down about 43% for the year so far.
Revenue, meanwhile, surged 371% to $45.9 billion, well above estimates of $40.35 billion. The company attributed the growth to a boost from hemp-foods producer Manitoba Harvest, which it acquired in February, the legalization of the Canadian adult-use market and growth in international medical markets, particularly in Europe.
The trip-digit revenue growth, however, was offset by surging costs and a fall in the price of weed sold per gram.
Cost of sales jumped to $33.63 billion compared to $5.57 billion a year earlier.
The average net selling price per gram decreased to $4.61 compared to $6.38 in the prior year period, with the company blaming the decline on a reduced mix of higher-priced extract products and a greater mix of lower-priced adult use.
Surging revenue growth combined with wider losses are not uncommon as cannabis producers continue to invest to ramp up manufacturing. But the decline in average selling prices raised fears of a possible oversupply, triggering a sea of red across weed stocks.
Cronos Group (NASDAQ:CRON), Canopy Growth (TSX:WEED) and Aurora Cannabis (TSX:ACB) were all nursing heavy losses for the day.
Canopy Growth’s fiscal first quarter results – due today after the closing bell – will likely provide investors with further insight into the supply-and-demand dynamics within the industry.© Reuters.
HIGH RISK INVESTMENT WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71.36% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
TRADE.com is a trade name operated by Trade Capital Markets (TCM) Limited (ex. Leadcapital Markets Limited), which is authorized and regulated by the Cyprus Securities and Exchange Commission, license number 227/14 and authorized by the FSCA, South Africa (FSP No. 47857). 148 Strovolos Avenue, 1st floor, CY 2048, Nicosia, Cyprus.
Restricted Jurisdictions: We do not establish accounts to residents of certain jurisdictions including Japan, Canada and USA. For further details please see Terms & Conditions.